← Back to Clinical Trials
Recruiting NCT07128030

NCT07128030 Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07128030
Status Recruiting
Phase
Sponsor Universidad Rey Juan Carlos
Condition Exercise Training
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2025-08-23
Primary Completion 2026-02-23

Eligibility & Interventions

Sex Female only
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2025-08-23 with a primary completion date of 2026-02-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study was to evaluate the feasibility, safety, and acceptability of a supervised, combined moderate-intensity aerobic and resistance training program designed to reduce pain sensitization in BCS with persistent pain. Secondary objectives included assessing changes in pain intensity, somatosensory sensitivity, and temporal summation, while tertiary objectives focused on improvements in quality of life and functional capacity.

Eligibility Criteria

Inclusion Criteria: * Adult women diagnosed with stage I-III breast cancer * Completion of active treatment (surgery, chemotherapy, and/or radiotherapy) at least 6 months prior to enrollment * Presence of persistent pain or altered sensation in the upper quadrant of the affected limb related to oncologic treatment Exclusion Criteria: * Bilateral breast cancer * Locoregional recurrence * Other malignancies * Pre-existing pain not related to cancer treatment * Neurological or cognitive disorders * Non-Spanish speakers * Contraindications to moderate-intensity physical activity

Frequently Asked Questions

Who can join the NCT07128030 clinical trial?

This trial is open to female participants only, studying Exercise Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07128030 currently recruiting?

Yes, NCT07128030 is actively recruiting participants. Visit ClinicalTrials.gov or contact Universidad Rey Juan Carlos to inquire about joining.

Where is the NCT07128030 trial being conducted?

This trial is being conducted at Madrid, Spain.

Who is sponsoring the NCT07128030 clinical trial?

NCT07128030 is sponsored by Universidad Rey Juan Carlos. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology